Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
China flag China · Delayed Price · Currency is CNY
23.60
-0.58 (-2.40%)
Feb 2, 2026, 4:00 PM EST

SHE:001367 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
3,6322,7962,989---
Market Cap Growth
32.62%-6.46%----
Enterprise Value
2,6321,8322,063---
Last Close Price
24.1618.3019.69---
PE Ratio
29.5722.8228.56---
PS Ratio
7.125.937.52---
PB Ratio
2.542.082.39---
P/TBV Ratio
2.762.112.43---
P/FCF Ratio
1366.7827.31128.99---
P/OCF Ratio
23.6216.7337.08---
EV/Sales Ratio
5.163.895.19---
EV/EBITDA Ratio
18.5213.9018.18---
EV/EBIT Ratio
21.2715.7020.45---
EV/FCF Ratio
990.3517.8989.04---
Debt / Equity Ratio
0.010.0100.000.00-
Debt / EBITDA Ratio
0.060.060.000.010.01-
Debt / FCF Ratio
3.230.080.010.010.02-
Asset Turnover
0.340.330.420.810.930.80
Inventory Turnover
2.172.051.572.152.472.25
Quick Ratio
9.099.3312.903.532.462.33
Current Ratio
10.3110.3114.955.353.513.46
Return on Equity (ROE)
9.05%9.45%12.18%25.91%29.36%23.04%
Return on Assets (ROA)
5.21%5.16%6.62%12.59%15.61%12.49%
Return on Invested Capital (ROIC)
24.73%32.36%33.13%48.12%61.17%45.27%
Return on Capital Employed (ROCE)
8.50%8.60%8.00%21.80%28.00%24.80%
Earnings Yield
3.41%4.38%3.50%---
FCF Yield
0.07%3.66%0.78%---
Dividend Yield
0.49%0.63%1.16%---
Payout Ratio
14.81%27.74%-0.66%17.48%85.77%
Buyback Yield / Dilution
-1.21%-9.35%-22.74%0.02%-0.16%
Total Shareholder Return
-0.72%-8.72%-21.58%0.02%-0.16%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.